The QualityStocks Daily Thursday, June 16th, 2022

Today's Top 3 Investment Newsletters

MarketClub Analysis(ADN) $3.9900 +243.97%

QualityStocks(ACOR) $0.6185 +54.47%

InvestorBrandNetwork(WTER) $0.4299 +7.99%

The QualityStocks Daily Stock List

Iconic Brands Inc. (ICNB)

Bloomfield Investment Club, QualityStocks, SmallCapVoice, AwesomeStocks, OTCPicks, DSR News, BestDamnPennyStocks, CoolPennyStocks, Global Equity Report, Nebula Stocks, 24-7 Stock Alert, Penny Invest, Penny Stock Hub, TheNextBigTrade, PHUB News, MicroStockProfit, AlphaTrade, Beacon Equity Research, The Observer, StockEgg, Broad Street, Stock Rich, Damn Good Penny Picks, smartOTC, Small Cap Firm, OtcWizard, Light Speed Stocks, Penny Stock Professor, Monster Stock Alerts, Morning Stock Picks, PREPUMP STOCKS, OTCBB Journal, PennyTrader Publisher, TopPennyStockMovers, Penny Picks, Penny Stock Explosion, PennyStockRumors.net, Penny Stock Newsletter and HotOTC reported earlier on Iconic Brands Inc. (ICNB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today released its financial results for the full year ended Dec. 31, 2021. Among the highlights, the company reported $4,960,016 in total revenue for the fiscal year, which reflected an approximately 74% increase of $2,111,103. “2021 was a historic year for our company and one that we believe will continue to pay dividends into the future,” said Iconic Chief Executive Officer Larry Romer. “We achieved many milestones during the year and have put in place a business plan that we expect to drive Iconic into its next phase of growth by building brands and working with some of the largest beverage brands in the world. Acquiring TopPop was a milestone that we believe has changed the trajectory of our business… As we enter into a new segment of the alcohol industry with our adult ice-pops, RTF, RTD and pouch products, we believe we are well positioned for the opportunities ahead for our brands and products within our portfolio.”

To view the full press release, visit https://ibn.fm/BAauC

About Iconic Brands Inc.

Iconic is a leader in the development, design and delivery of alcohol and non-alcohol beverages. TopPop, its wholly owned subsidiary, is a leader in the innovation of low calorie, “ready to go” drinks – ready-to-freeze (“RTF”) and ready-to-drink (“RTD”) products in sustainable, flexible and stand-up pouch packaging and in the alcohol ice-pop and “cocktails-to-go” market. Iconic’s brands include “Bellissima” by Christie Brinkley, a premium better-for-you and better-for-the-planet collection of Prosecco, Sparkling Wines and Still Wines, all of which are certified vegan and made with organic grapes. Bellissima is strategically positioned with its zero sugar wines in the zero sugar beverage category. The company operates in multiple states, distributes across the globe and has Fortune 500 customers that include some of the world’s largest alcohol beverage companies and brands. For more information, visit www.IconicBrandsUSA.com.

Iconic Brands Inc. (ICNB), closed Thursday's trading session at $0.31, up 11.1111%, on 94,246 volume. The average volume for the last 3 months is 94,246 and the stock's 52-week low/high is $0.255/$1.00.

Warrior Met Coal Inc. (HCC)

MarketBeat, StreetInsider, INO.com Market Report, The Online Investor, Zacks, The Street, Trades Of The Day, Daily Trade Alert, QualityStocks, BUYINS.NET, StockMarketWatch, MarketClub Analysis, Schaeffer's, StreetAuthority Daily, AllPennyStocks, Market Intelligence Center Alert, InvestorPlace, Street Insider, CRWEFinance, TopStockAnalysts and SmarTrend Newsletters reported earlier on Warrior Met Coal Inc. (HCC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

On average, coal power plants generate around 45% of America’s electricity. Coal is one of the cheapest and most abundant sources of electricity, allowing energy providers to generate electricity at relatively little cost.

However, coal is also one of the largest emitters of carbon on the planet. In a bid to arrest greenhouse gas emissions, entities around the world are moving away from coal to more renewable sources of energy.

In Illinois, for example, the state government is incentivizing the transition from coal power to green electric energy by providing companies with millions of dollars in grants. The state will award up to $280.5 million in grants to companies that commit to building new battery energy storage facilities on old coal power plant sites.

The grants will be provided by the recently passed Climate and Equitable Jobs Act (CEJA). The bill is part of Illinois’ efforts to achieve 50% renewable energy by 2040 and 100% carbon-free electricity production by 2050.

One of the bill’s main focuses is a transition away from coal via the Coal to Solar and Storage Initiative. The initiative will provide funding of up to $28.05 million per year at $110,000 per megawatt of storage capacity.

Officials have already selected five projects and will be paying out the grants over a 10-year period. Two companies with 72MW energy storage projects will each be awarded $79.2 million in grants while three companies with smaller 37MW energy storage projects will receive $40.7 million each.

NRG Midwest Storage plans on building two energy storage facilities and will receive $79.2 million for each project. Dynegy Midwest Generation, Electric Energy Inc. (Vistra) and Illinois Power Resources Generating LLC (Vistra) will receive $40.7 million in grants each.

Vistra Energy CEO Curt Morgan welcomed the Coal to Solar scheme, lauding it for being the first program in the country to begin the transition from coal power plant sites to renewable energy centers. Although Vistra Energy acquired its Illinois coal power plant in 2018, it has stated that it already plans to shut it down by 2027.

Each of the coal plants that has been selected for the grant program is also in the process of shutting down, said the Illinois Department of Commerce and Economic Opportunity (DCEO). The department has been charged with overseeing the transition from coal to battery storage.

Stationary energy storage will be critical for a smooth transition to cleaner sources of energy. DCEO director Sylvia I. Garcia said that the Coal to Solar Energy Storage program will be critical to shoring up the electrical grid, helping the environment and strengthening the economy.

Before different jurisdictions can make the switch to green forms of energy, there will be a thriving market for coal from mining companies such as Warrior Met Coal Inc. (NYSE: HCC).

Warrior Met Coal Inc. (HCC), closed Thursday's trading session at $33.43, off by 2.137%, on 1,485,047 volume. The average volume for the last 3 months is 1.485M and the stock's 52-week low/high is $15.81/$42.95.

Lucid Motors (LCID)

Green Car Stocks, InvestorPlace, Schaeffer's, MarketClub Analysis, The Street, MarketBeat, Trades Of The Day, Kiplinger Today, Daily Trade Alert, QualityStocks, The Online Investor, StocksEarning and Investopedia reported earlier on Lucid Motors (LCID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American electric car maker Lucid Motors (NASDAQ: LCID) has unveiled a digital financing platform dubbed Lucid Financial Services to provide Air EV customers in America with leasing and loan purchase options. Lucid Motors has partnered with the Bank of America to provide the financing options.

Lucid Motors first announced that production on the Lucid Air EV had begun in September 2021 with deliveries expected to begin in late 2022. Despite struggling to meet production targets because of supply chain constraints coupled with recalls, Lucid’s Air EV has been met with positive reviews.

At the moment, the Newark, California-based company is delivering the second trim level of the Air EV Sedan. Lucid’s flagship electric sedan will have four available trims in total, with the least expensive trim costing $77,400 and the most expensive trim going for a cool $169,000.

A small percentage of Americans can afford to buy an electric vehicle outright, not to mention the cost of installing a charger at home. With the average EV costing thousands of dollars more than its combustion engine counterpart, a significant percentage of EV sales have relied on government incentives and subsidies.

Lucid’s offerings are anything but average. The company is looking to become a major player in the luxury electric vehicle segment, and its prices are representative of that. However, the new Lucid financial services platform will allow people who wouldn’t have been able to afford the Lucid Air otherwise to buy or lease a vehicle.

Lucid customers will now be able to handle their entire purchase digitally, thanks to Lucid’s new platform. The platform will also allow customers to complete their financing applications and sign the purchase contract online, thanks to a strategic partnership with Bank of America.

The EV maker wrote in a media room post that Lucid Air customers had requested “flexible financing options,” with many of them preferring a 100% digital experience when making their purchases. On top of completely digitizing the entire experience, Lucid will also provide customers with personalized support to help them navigate the Lucid financial services platform with ease.

The Bank of America is promising to provide Lucid Air customers with competitive financing rates. Prospective Lucid Air customers will be able to apply for purchase loans of various terms or lease terms for 24, 36 or 48 months.

American customers who are currently accepting deliveries for the Air Grand Touring EVs as well as future customers accepting deliveries of the Pure and Touring models later this year will be able to access the digital financing platform.

Lucid Motors (LCID), closed Thursday's trading session at $15.55, off by 11.2443%, on 19,089,824 volume. The average volume for the last 3 months is 18.805M and the stock's 52-week low/high is $13.25/$57.75.

Hillcrest Energy Technologies Ltd.'s (HLRTF)

Profitable Trader Authority, PennyStockScholar, OTCtipReporter, PennyStockProphet, PennyPickGains, Penny Pick Finders, Buzz Stocks, Pennystockmania, StockOnion, StockWireNews, QualityStocks, Small Cap Firm, Penny Stock 101, StockRockandRoll, HotOTC, Fierce Analyst, PennyStockLocks and StockStreetWire reported earlier on Hillcrest Energy Technologies Ltd.'s (HLRTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean tech company developing transformative power conversion technologies and control solutions, is positioned amid accelerated momentum to electrify and decarbonize energy systems. In the midst of reimaging an energy future, an unassuming power electronics hero has emerged: the power inverter, which holds the key to unlock efficiency and performance improvements. Hillcrest offers a single inverter architecture that can be applied at nearly every stage of the evolving electrification ecosystem to provide full-cycle efficiency and performance improvements. “Our clean-energy technologies specifically target efficiencies in electric machines and can be deployed to maximize performance across a wide variety of applications within the electric ecosystem, from electric vehicles, energy storage systems to grid-connected power generation,” said Hillcrest CEO Don Currie. “In addition to scaling our in-house development and design capabilities, Hillcrest has initiated targeted discussions with strategic partners with the potential to scale with us.”

To view the full press release, visit https://ibn.fm/Rg1BI

About Hillcrest Energy Technologies Ltd.

Hillcrest is a clean technology company developing high value, high performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. Hillcrest is publicly traded on the CSE under the symbol HEAT, on the OTCQB Venture Market as HLRTF and the Frankfurt Stock Exchange as 7HIA.F. For more information, please visit www.HillcrestEnergy.tech.

Hillcrest Energy Technologies Ltd.'s (HLRTF), closed Thursday's trading session at $0.1026, off by 4.291%, on 154,952 volume. The average volume for the last 3 months is 154,952 and the stock's 52-week low/high is $0.075/$0.193.

Cango (CANG)

The Online Investor, StreetInsider, StocksEarning, QualityStocks, InvestorPlace, Zacks, RedChip, MarketBeat, FreeRealTime and BUYINS.NET reported earlier on Cango (CANG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cango Inc. (NYSE: CANG) (FRA: 9C0A) is a service firm that operates as an automotive transaction service platform that links car buyers, financial institutions and original equipment manufacturers and dealers in China.

The firm has its headquarters in Shanghai, the People’s Republic of China and was incorporated in August 2010 by Xiao Jun Zhang and Jia Yuan Lin. It operates as a part of the technology sector, under the technology services sub-industry and serves consumers in China.

Its services are mainly made up of automotive transaction facilitation, after-market services facilitation and automotive financing facilitation. It also provides integrated solutions which support the cycle of automotive financing transactions. These include delinquent asset management services, credit servicing, credit assessment and credit origination. The company also offers additional services, which include the facilitation of care purchases for individuals who’d like to buy cars, vehicle sourcing, warehousing and logistics support for dealers. This is in addition to facilitating after-market services to individuals who’d like to buy a vehicle, which include facilitating the sale of insurance policies from firms or insurance brokers. The products provided via its platform include automotive and personal accident insurance.

The enterprise’s extensive, technology-enabled service offerings in the automotive value chain allow the company to attract more participants to its platform and improve the engagement of existing participants. Its comprehensive data insight built upon its technology also offers the company a competitive edge in possible value-added service offerings, which may be useful in encouraging more investments into the firm.

Cango (CANG), closed Thursday's trading session at $3.14, up 40.1786%, on 1,586,457 volume. The average volume for the last 3 months is 1.575M and the stock's 52-week low/high is $1.95/$6.04.

Acorda Therapeutics (ACOR)

The Street, StreetInsider, Marketbeat, InvestorPlace, SmarTrend Newsletters, StockMarketWatch, Marketbeat.com, Schaeffer's, Zacks, BUYINS.NET, Daily Trade Alert, Penny Sleuth, Whiskey & Gunpowder, Greenbackers, MarketClub Analysis, Hit and Run Candle Sticks, AllPennyStocks, CNBC Breaking News, Money Morning, Street Insider, Streetwise Reports, TraderPower, Barchart, Daily Markets, Darwin Investing Network, FNNO Newsletters, Average Joe Options, Investopedia, Momentum Traders, PowerRatings Stocks, QualityStocks, SECFilings.com News, Super Stock Picker, Trades Of The Day, WealthMakers and MarketWatch reported earlier on Acorda Therapeutics (ACOR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Acorda Therapeutics Inc. (NASDAQ: ACOR) (FRA: CDG0) is a biopharmaceutical firm that is engaged in the development and commercialization of therapies for neurological disorders in order to restore function and improve the lives of patients living with neurological disorders.

The firm is based in Ardsley, New York and was incorporated in 1995 by Ronald Cohen. It operates as part of the healthcare sector, under the biotech and pharma sub-industry and serves consumers across the globe.

The company is party to a license and collaboration agreement with Biogen Inc., which entails developing and commercializing of Ampyra. It is also developing multiple approaches for the repair and regeneration of the brain and spinal cord.

The enterprise’s products include a formulation known as CVT-301 (Inbrija), for treating OFF periods in patients with Parkinson’s disease; a formulation developed to treat alcohol dependence known as Selincro, and an oral drug developed to improve walking in patients who suffer from multiple sclerosis known as dalfampridine (Ampryra). In addition to this, it also develops Cimaglermin alfa (CVT-427), for heart failure patients; rHIgM22, which concluded phase 1 clinical trials evaluating its effectiveness in treating patients with multiple sclerosis and an ARCUS product for treating acute migraines. The enterprise markets Ampyra as Fampyra in the Americas, Asia and Europe.

The company recently entered into a distribution and supply agreement with Esteve Pharmaceuticals, which will allow it to commercialize its Inbrija formulation in Spain. This move will help extend the company’s consumer reach, which will have a positive effect on its growth and encourage more investments into the firm.

Acorda Therapeutics (ACOR), closed Thursday's trading session at $0.6185, up 54.4705%, on 53,534,157 volume. The average volume for the last 3 months is 53.303M and the stock's 52-week low/high is $0.27625/$6.36.

Right On Brands (RTON)

QualityStocks, SmallCapVoice and TopPennyStockMovers reported earlier on Right On Brands (RTON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Right On Brands Inc. (OTC: RTON) is a consumer and media firm that is focused on marketing and selling various snack foods which have been enhanced with hemp.

The firm has its headquarters in Rowlett, Texas and was incorporated in 2011, on April 1st by Vicki L. Yawn and Johnie M. Yawn. Prior to its name change in August 2017, the firm was known as HealthTalk Live Inc. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm has five companies in its corporate family and serves consumers in the United States.

The company conducts its business through wholly-owned subsidiaries, including Humble Water Company, Endo Brands and Humbly Hemp. Humble Water Company is party to a partnership with Springhill Water Company, for the development of a line of natural mineral water, high alkaline and a bottling and packaging facility. Humbly Hemp is involved in the sale and marketing of a line of hemp-enhanced snack foods.

The enterprise products include a pre-rolled cannabinoid flower in the shape of a cigarette dubbed Endo Tokes; a topical pain relief product known as Endo Ease; and a wellness drink known as Endo Drops. It also provides Humbly Hemp sparkling tea; Humbly Hemp snack bars; and Endo gummies. The enterprise sells health and wellness products in the hemp marketplace through in-person and online retail sales.

The firm, which recently opened a pair of new locations in Laredo and Austin, is focused on expanding to different parts of the country. This, coupled with its recently launched product line, will help extend the firm’s consumer reach and bring in additional revenue as well as investors.

Right On Brands (RTON), closed Thursday's trading session at $0.0008, up 60%, on 494,574,048 volume. The average volume for the last 3 months is 494.574M and the stock's 52-week low/high is $0.0003/$0.0055.

Ekso Bionics (EKSO)

Total Wealth, QualityStocks, Money Morning, MarketClub Analysis, StockMarketWatch, MarketBeat, Epic Stock Picks, Daily Trade Alert, CustomerService, Promotion Stock Secrets, TraderPower, TopPennyStockMovers, InvestorPlace, PennyStocks24, BUYINS.NET, Marketbeat.com, Penny Pick Finders, Pennybuster, PennyStockProphet, PennyStockRumors.net, StreetInsider, Weekly Wizards, Wolf of Penny Stocks, Stock Analyzer, Uncommon Wisdom, PricelessPennyStocks, Buzz Stocks, Wall Street Mover, TopStockAnalysts, EpicVIP Group, Investing Daily, Top Pros' Top Picks, Planet Penny Stocks, The Observer, StreetAuthority Daily, MonsterStocksPicks, StockOnion, Stock Stars, Short Term Wealth, Actual Gains and The Online Investor reported earlier on Ekso Bionics (EKSO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) (FRA: 23E2) (LON: 01FR) is focused on designing, developing, renting and selling exoskeleton products.

The firm has its headquarters in Richmond, California and was incorporated in 2012, on January 30th. It operates as part of the medical instruments and supplies industry, under the healthcare sector. The firm serves consumers in the Asia Pacific, Africa, the Middle East, Europe and the Americas.

The company is party to a license agreement with Lockheed Martin Corp. It operates through the EksoWorks and the EksoHealth segments. The former segment is engaged in the provision of exoskeleton devices that allow able-bodied individuals to perform heavy-duty work for an extended period of time. On the other hand, the latter segment is involved in engineering, manufacturing and selling exoskeletons for applications in the medical markets.

The enterprise provides a wearable upper extremity assistive device dubbed EksoUE, which helps decrease the effect of gravity on the arms and shoulders of an individual who wears it. It also offers a wearable bionic suit and rehabilitation device known as EksoNR, which helps physicians and physical therapists to treat patients with acquired spinal cord injuries, stroke and brain injuries. This is in addition to offering research for the advancement of projects that will benefit America’s defense capabilities.

The firm recently received clearance from the FDA to market its EksoNR device to be used by patients with multiple sclerosis. This move will not only benefit patients with this indication but also encourage more investments into the firm and bolster its growth.

Ekso Bionics (EKSO), closed Thursday's trading session at $1.74, off by 7.4468%, on 213,696 volume. The average volume for the last 3 months is 213,696 and the stock's 52-week low/high is $1.535/$5.88.

Electro-Sensors (ELSE)

SmarTrend Newsletters, Wall Street Resources, StreetInsider, MarketBeat, Marketbeat.com, TradersPro, StockMarketWatch, OTCBB Journal, BUYINS.NET and Broad Street reported earlier on Electro-Sensors (ELSE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Electro-Sensors, Inc. (NASDAQ: ELSE) is focused on manufacturing and selling industrial production monitoring and process control systems.

The firm has its headquarters in Minnetonka, Minnesota and was incorporated in 1968 by James P. Slattery. It operates as part of the scientific and technical instruments industry, under the technology sector. The firm serves consumers around the globe.

The enterprise is involved in manufacturing and selling a range of monitoring and control systems which measure machine operation and production rates, as well as regulate the speed of machines in production processes. Its systems to monitor speed include products which can measure production rates or counts, like board feet, gallons or parts; tachometers and alarm systems. The enterprise’s temperature application products include motor, gear box and bearing temperature monitoring sensors. It also provides production monitoring devices including tilt switches; vibration monitoring products; slide gate position and belt alignment monitors. In addition to this, the enterprise offers hazard monitoring systems, including its HazardPRO site system manager software, and Electro-Sentry. The enterprise sells its products through its internal sales team as well as through distributors and manufacturer’s representatives in Canada, the U.S., the UAE, the U.K. South Africa, Germany, Egypt, Mexico, Singapore, India, Tunisia, Ukraine, Chile, Thailand, the Philippines, Malaysia, Vietnam, the Republic of Korea, China, Australia and Guatemala.

The company recently announced that it planned to merge with Mobile X Global Inc. This move will enable the creation of shareholder value and position both companies for rapid growth.

Electro-Sensors (ELSE), closed Thursday's trading session at $5.6, off by 1.7544%, on 13,417 volume. The average volume for the last 3 months is 13,417 and the stock's 52-week low/high is $4.4501/$6.76.

Cvent Holding Corp. (CVT)

StreetInsider, INO.com Market Report, MarketClub Analysis, Marketbeat.com, The Street, Zacks, AllPennyStocks, Traders For Cash Flow, Stock News Now, OTCJournal, TopStockAnalysts, MarketBeat, Investors Alley, Investing Futures, BUYINS.NET and Money Morning reported earlier on Cvent Holding Corp. (CVT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cvent Holding Corp. (NASDAQ: CVT) is a software firm that is engaged in the provision of a cloud-based enterprise event management, marketing and hospitality platform for events and meeting value ecosystem.

The firm has its headquarters in Tysons, Virginia and was incorporated in 1999 by Dwayne J. Sye, David C. Quattrone, Charles V. Ghoorah and Rajeev K. Aggarwal. It operates as part of the software-application industry, under the technology sector. The firm has five companies in its corporate family and serves consumers in the United States.

The enterprise’s hospitality cloud solutions are offered to destinations, venues and hotels with online marketing solutions for marketing their events to planners. It also offers software solutions which automate the events sales cycle and enhances collaborations with planners to plan for and manage events. Its event cloud solutions include event management and marketing services which allow planners and marketers to maximize return on investment and engagement from their virtual, hybrid or in-person events. In addition to this, the enterprise offers cloud-based online hospitality marketing solutions which allow suppliers to market and advertise on venue sourcing networks like Cvent wedding spot, CventSpeedRFP and CSN. It sells its platform primarily via a direct inside sales team.

The company’s recently announced financial results show significant increases in its revenues. It remains focused on positioning itself for continued growth in the market, which will not only bring in additional revenues and investments but will also help create value for its shareholders.

Cvent Holding Corp. (CVT), closed Thursday's trading session at $4.79, up 0.630252%, on 497,993 volume. The average volume for the last 3 months is 495,899 and the stock's 52-week low/high is $3.30/$10.9626.

Absci Corp. (ABSI)

MarketBeat and StocksEarning reported earlier on Absci Corp. (ABSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AbSci Corp. (NASDAQ: ABSI) is a drug and target discovery firm that is engaged in the provision of biologic drug candidates and production cell lines through the use of an integrated drug creation platform for partners.

The firm has its headquarters in Vancouver, Washington and was incorporated in 2011. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector. The firm has five companies in its corporate family and serves consumers in the United States.

The company’s objective is to unlock the potential of next generation biologics with a new approach to cell line development and biologic drug discovery. It hopes to expand biological possibility and translate its partners’ ideas into market-ready drugs.

The enterprise specializes in the production of disulfide proteins which are soluble and range from monoclonal antibodies to insulin in cytoplasm via secretion into the periplasmic space. This allows the healthcare industry to mass-produce these medical compounds. It has also developed an integrated drug creation platform to find new drug targets, develop bio-therapeutic candidates and generate cell lines to manufacture the candidates in one process. The enterprise uses deep learning AI and synthetic biology technologies to forecast, find, design, construct, select and scale biologic drug candidate production. It has drug candidates in 9 active programs, 8 of which are focused on developing cell lines for formulations that its partners are developing.

The firm is currently focused on enhancing its technology platform, embarking on new collaborations and advancing its partnered programs. This will positively influence its revenues while also bolstering its growth, which will be good for investments.

Absci Corp. (ABSI), closed Thursday's trading session at $3.41, off by 5.8011%, on 920,363 volume. The average volume for the last 3 months is 912,845 and the stock's 52-week low/high is $2.93/$31.5301.

GoPro Inc. (GPRO)

InvestorPlace, The Street, Schaeffer's, MarketClub Analysis, StreetInsider, StocksEarning, Money Morning, Daily Trade Alert, INO.com Market Report, InvestorGuide, Barchart, Daily Wealth, MarketBeat, Total Wealth, Marketbeat.com, Market Intelligence Center Alert, Uncommon Wisdom, Investopedia, Kiplinger Today, StreetAuthority Daily, Street Insider, CustomerService, MarketWatch, Wyatt Investment Research, The Online Investor, The Growth Stock Wire, Trades Of The Day, Zacks, TopStockAnalysts, Investor Guide, Investors Alley, Hit and Run Candle Sticks, TheStockAdvisor, StrategicTechInvestor, Daily Markets, Money and Markets, Profit Confidential, Trading Concepts, StockMarketWatch, TradersPro, Wealth Insider Alert, Daily Profit, Cabot Wealth, AllPennyStocks, Rick Saddler, Louis Navellier, BUYINS.NET, Weekly Wizards, Dynamic Wealth Report, WStreet Market Commentary, Wall Street Daily, CNBC Breaking News, CitronResearch.com, Options Elite, GorillaTrades, Insider Wealth Alert, Investing Futures, The Best Newsletters, Wall Street Greek, Jason Bond, InvestmentHouse, Investiv, Investing Lab, Greenbackers, Dividend Opportunities, Energy and Capital, SmallCapNetwork, The Street Report, 24/7 Trader, SmallCap Network, SmallCapVoice, SmarTrend Newsletters, ProfitableTrading, Traders For Cash Flow, Market Intelligence Center, The Weekly Options Trader, Direction Alerts, CrashTrade, Darwin Investing Network, Wallstreet Journal and WallStreet Profits reported earlier on GoPro Inc. (GPRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GoPro Inc. (NASDAQ: GPRO) (LON: 0R1C) (FRA: 5G5) (BMVF: GPRO34) (ETR: 5G5) is focused on the development and sale of mountable and wearable accessories, cameras and subscription services and software.

The firm has its headquarters in San Mateo, California and was incorporated in 2002 by Nicholas Woodman. Prior to its name change in February 2014, the firm was known as Woodman Labs Inc. It operates as part of the consumer electronics industry, under the technology sector. The firm serves consumers around the globe, with a focus on the United States.

The enterprise’s products include a mobile app known as Quik app, which allows users to get their favorite videos and photos with footage from any camera or phone; a subscription service dubbed GoPro, which includes complete access to Quik app, damage protection, camera replacement and cloud storage supporting source photo and video quality; and a 360o waterproof camera known as MAX. It also provides cloud connected HERO8, HERO9 and HERO10 Black waterproof cameras. The enterprise also provides accessories and mounts including equipment-based mounts comprising of roll bar, handlebar, tripod and helmet mounts, lifestyle gear, cables, charging accessories, dive filters and spare batteries. In addition to this, it offers web and mobile applications which provide media workflow for editing, sharing content, archiving and multi-clip story creation on the go.

The company recently announced its latest operating and financial results, which show increases in its revenues and significant growth in its subscribers. It is currently focused on launching new products as it shifts into a more subscription-centric business. This will bring in additional revenues into the firm while helping to extend its consumer reach, which will be good for its growth.

GoPro Inc. (GPRO), closed Thursday's trading session at $5.76, off by 3.6789%, on 1,998,589 volume. The average volume for the last 3 months is 1.992M and the stock's 52-week low/high is $5.565/$12.305.

The QualityStocks Company Corner

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

  • The majority of music industry revenue is not distributed to artists but to the labels and distribution companies that own them
  • Friendable’s flagship offering, in conjunction with the recently acquired Artist Republik and FeaturedX, offers artists a 360-degree platform for music creation, distribution, and marketing – a one-of-a-kind experience
  • TuneCore announced that it would be changing its pricing structure, making it more affordable for musicians looking to distribute their music on their own, but has not changed offering to include all of the Fan Pass Live solutions

In the past, artists looking to distribute their music had very few options, and these options were often linked to a relationship with a record label. In 2018, Rolling Stone published an article about how much musicians bring home from the revenue earned in the music industry – 12%. That is not 12% per musical artist, but the industry as a whole. At that time, the industry was valued at $43 billion across on-demand streaming, CD sales, radio play, live events, and advertising. Still, artists only shared a small portion of these earnings ($5 billion) (https://ibn.fm/S0TSp). One of the biggest pain points faced by independent music artists in the industry today is the high cost associated with creating, distributing, and marketing their music. In July 2020, Friendable (OTC: FDBL) released the Fan Pass Live artist platform and has since grown exponentially, increasing the number of artists and acquiring Artist Republik and FeaturedX in January 2022. Combined, Fan Pass Live now offers a 360-degree artist platform that embraces creation, distribution, and marketing – minus label control, in what can be described as an “anti-label” movement.

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Thursday's trading session at $0.00025, up 28.2051%, on 77,604,973 volume. The average volume for the last 3 months is 77.605M and the stock's 52-week low/high is $0.000195/$0.018.

Recent News

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

  • Global efforts to address climate change are expected to drive an economic market that Special Presidential Envoy for Climate John Kerry argues will ultimately be larger than the Industrial Revolution was
  • While energy efficient commercial buildings have rapidly increased in the United States and Canada during recent years, the mission of sustainability must be spread among construction and development professionals. 
  • Green energy solutions company Correlate Infrastructure Partners Inc. is helping companies reduce their carbon footprint through it’s data-centric platform for analyzing corporate facilities’ energy usage and spearheading their sustainability solutions 
  • Correlate’s services make it possible for companies to be apart of the solution by achieving greater energy efficiency and access to locally sited solar, energy storage and EV infrastructure

While climate change worries have been expressed as a threat to future life, Special Presidential Envoy for Climate John Kerry recently cast a more optimistic vision of the potential that climate change represents in terms of economic possibilities. “This is the largest market the world has ever been staring at: the energy transition market,” Kerry told attendees at the IV CEO Summit of the Americas in Los Angeles on June 9 (https://ibn.fm/4IbtG). “Every aspect of life can be impacted in a positive way. It’s not something to fear — that we have to shun and shy away from. We have to embrace this transition which will, in the end, I guarantee you, be larger than ultimately than the Industrial Revolution was.” Louisiana-based Correlate Infrastructure Partners (OTCQB: CIPI) is a purpose-built energy use optimization company pursuing green utilities solutions for the commercial real estate industry. They are innovating the industry with the mission of sustainability, and the kickback of increased net operating income. The company is one of many whose enthusiasm mirrors Kerry’s faith in the idea that finding solutions for reducing carbon emissions is sound business sense. 

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.

Subsidiaries

Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Thursday's trading session at $1.1, even for the day, on volume. The average volume for the last 3 months is 250 and the stock's 52-week low/high is $0.30/$3.25.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Dr. Markus Roggen, president and CSO of Delic Labs, and his participation in the upcoming Grow Up Conference and Expo. During the event taking place on June 20-22, 2022, in Victoria, British Columbia, Dr. Roggen will participate in multiple panels and share details on the advancement of psychedelics as well as improvements of cannabis extraction technology. Interested parties should visit https://ibn.fm/UXl5c to learn more about the Grow Up Conference and Expo and purchase tickets for the engaging three-day event. To view the full press release, visit https://ibn.fm/I8jHL

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Thursday's trading session at $0.0424, even for the day, on 52 volume. The average volume for the last 3 months is 52 and the stock's 52-week low/high is $0.0309/$0.315.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, through Sequire, its SaaS platform, hosted the 2022 LD Micro Invitational. The invitation was held June 7–9, 2022, in both an in-person and virtual format; those attending in person gathered in Westlake, California. The event included 187 companies that each provided a 25-minute presentation. Those presentations are now available online. SRAX noted that some of the most viewed presentations include Cel-Sci Corporation (NYSE: CVM)NaturalShrimp Inc. (OTCQB: SHMP)22nd Century Group Inc (NASDAQ: XXII)Humanigen Inc. (NASDAQ HGEN), and Lightwave Logic Inc. (NASDAQ: LWLG), to name a few. The replays will be available for three months. To view the full presentations, visit https://ibn.fm/Xg7mN. To view the full press release, visit https://ibn.fm/n7TFH

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Thursday's trading session at $3.23, off by 3.869%, on 34,729 volume. The average volume for the last 3 months is 34,729 and the stock's 52-week low/high is $3.00/$6.50.

Recent News

Cepton Inc. (NASDAQ: CPTN)

The QualityStocks Daily Newsletter would like to spotlight Cepton Inc. (NASDAQ: CPTN).

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, today announced the opening of its new corporate office in Metro Detroit (Troy, Michigan). According to the update, the location will serve as Cepton’s automotive hub as it continues to expand its active engagements and initiatives with original equipment manufacturers (“OEMs”). “I’m incredibly proud that our Silicon Valley company, Cepton, has earned Detroit’s trust,” said Dr. Jun Pei, Cepton’s co-founder and CEO. “As we continue to expand our engagements with all of the top ten global OEMs, locating our experienced team in Detroit will serve us well. Our expanded footprint will help us reach our goal of making lidar a standard safety feature in the cars of today and the key component in the autonomous vehicles of the future.” To view the full press release, visit https://ibn.fm/nALOm

Cepton Inc. (NASDAQ: CPTN) is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE:GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (MMT®) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications.

Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China.

Micro Motion Technology (MMT®)

Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration.

Key among its innovations is MMT®, a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

  • Reliability – The durable design uses common, easily attainable materials.
  • Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view.
  • Efficiency – MMT® features a compact form factor, low power usage and inexpensive components.
  • Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable.

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (ADAS) integration, whether behind windshield, in headlamp or in fascia.

Agreement with KOITO

KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT® based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (AV) applications.

Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027.

On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (PIPE) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s recent merger.

Collaboration with GM

On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system.

GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (ADAS) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.”

On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.”

Market Outlook

Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years.

The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America.

In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs.

Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come.

Management Team

Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies.

Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University.

Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering.

Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University.

[1] Largest known ADAS lidar series production award based on number of vehicle models awarded

Cepton Inc. (NASDAQ: CPTN), closed Thursday's trading session at $1.29, off by 11.0345%, on 1,130,972 volume. The average volume for the last 3 months is 1.131M and the stock's 52-week low/high is $1.01/$80.16.

Recent News

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors has authorized the repurchase of up to $5 million of its outstanding common shares as market conditions and the company’s liquidity warrant. “We believe that the potential to repurchase our shares at these levels represents a compelling opportunity to deploy available cash to drive shareholder value,” said Luis Merchan, Flora’s chairman and CEO. “Flora continues to move assertively to execute its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses. We are confident in the company’s short, medium and long-term growth prospects based on our strong in-market brand portfolio together with our cultivation and export capabilities and life sciences research. The repurchase program affords us the opportunity to increase our ownership in our portfolio of high-quality brands through our shares, which in our view are trading well below NAV.” To view the full press release, visit https://ibn.fm/dQn7L. Thailand made headlines last week when it became the first country in Asia to decriminalize marijuana, making it legal to grow and sell or use for medicinal reasons. Thai Health Minister Anutin Charnvirakul expects legal cannabis production to boost the economy, but warned that recreational cannabis use remains illegal. The public health minister also launched a plan to distribute 1 million marijuana seedlings with a THC level below 0.2% to households across Thailand for medicinal purposes. Cannabis decriminalization in Thailand opens up a new market for cannabis companies like Flora Growth Corp. (NASDAQ:FLGC), OrganiGram Holdings Inc . (NASDAQ:OGI) (TSX:OGI), Cronos Group (NASDAQ:CRON) (TSX:CRON), Canopy Growth Corp. (TSX:WEED) (NASDAQ:CGC), and Zynerba Pharmaceuticals (NASDAQ:ZYNE).

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.

Cultivation

Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Thursday's trading session at $0.6496, off by 7.2%, on 8,724,047 volume. The average volume for the last 3 months is 8.712M and the stock's 52-week low/high is $0.61/$21.45.

Recent News

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF)

The QualityStocks Daily Newsletter would like to spotlight Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF).

  • Eat Well Investment Group has focused on expanding its product offerings, targeting both small and large businesses, and has successfully grown its retail footprint with the addition of notable retailers in both the U.S. and Canada
  • Its aggressive expansion has seen Eat Well serve customers in over 35 countries, with projected revenue of $100 million in 2022
  • The company is confident that, with current opportunities in the plant-based sector, it will achieve its 2022 revenue target and create value for its shareholders

At the close of the 2021 calendar year, Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) announced the appointment of Marc Aneed as its new Chief Executive Officer (“CEO”). Mr. Aneed, having taken over from retiring David Doherty, assured investors that the company would also remain focused on driving shareholder value into 2022 and beyond (https://ibn.fm/bbreb).

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022.

Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company.

The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products.

Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada.

Portfolio

On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein.

Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today.

Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch.

Market Outlook

According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research.

Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply.

Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition.

The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue.

Management Team

Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales.

Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing.

Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management.

Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses.

Strategic Advisory Board

HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth.

Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter.

Eat Well Investment Group Inc. (OTC: EWGFF), closed Thursday's trading session at $0.18876, off by 0.652632%, on 2,800 volume. The average volume for the last 3 months is 2,800 and the stock's 52-week low/high is $0.18/$1.00.

Recent News

Aditxt Inc. (NASDAQ: ADTX)

The QualityStocks Daily Newsletter would like to spotlight Aditxt Inc. (NASDAQ: ADTX).

Liver transplants have saved thousands of lives around the world. The procedure itself can be extremely challenging and resource intensive though, as it often requires specialized machinery and the input of dozens of high-level specialists. Furthermore, donor livers are scarce, and doctors often have a narrow window of eight to twelve hours before they have to transplant a liver after extraction. This means that liver transplants often require precise coordination to ensure the donor liver is still viable by the time it reaches the recipient. This team’s research adds onto the work being done by other companies sech as Aditxt Inc. (NASDAQ: ADTX) to find ways of modulating the immune system so that transplanted organs aren’t rejected by the host.

Aditxt Inc. (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore™, which is designed to provide a personalized profile of the immune system.

The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy™ (“ADi™”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi™ products for psoriasis, type 1 diabetes, and skin grafting.

Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York.

AditxtScore™

AditxtScore™ is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities.

The company’s first commercial application of the platform, AditxtScore™ for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances.

Aditxt’s AditxtScore™ immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore™ as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually.

ADi™

ADi™ is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy™ (ADi™) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi™ technology platform can be engineered to address a wide variety of indications.

Aditxt is currently developing ADi™ products for psoriasis, type 1 diabetes and skin grafting.

Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

  • Can be made into a product
  • Does not require additional hospitalization
  • Is simple to produce and ship

Preclinical studies have demonstrated that ADi™ treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi™ treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin.

IP Portfolio

Both AditxtScore™ and ADi™ are supported by a strong IP portfolio.

AditxtScore™, built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses.

ADi™ technology is protected by seven patent families, including:

  • 8 U.S. patents
  • 4 pending U.S. patent applications
  • 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

  • Autoimmune diseases and Type 1 Diabetes
  • Organ transplantation and a method of producing plasmid DNA to prevent immune activation
  • Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies.

Market Overview

The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms.

The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses.

Through its focus on the COVID-19 testing market with AditxtScore™, Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore™ platform.

Leadership Team

Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive.

Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology.

Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions.

Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant.

Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense.

Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions.


Aditxt Inc. (NASDAQ: ADTX), closed Thursday's trading session at $0.159, off by 11.1732%, on 2,961,836 volume. The average volume for the last 3 months is 2.898M and the stock's 52-week low/high is $0.1562/$3.95.

Recent News

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Psychonauts have long talked about how profoundly psychedelics can affect your mental well-being, with many of these individuals revealing that psychedelics changed their lives. In recent years, psychedelics have seen a resurgence in popularity as more people use them recreationally, for medical purposes and as part of their spiritual journeys. Now new research has found that hallucinogens, specifically psilocybin, may have positive long-lasting psychological effects. Drummond E-Wen McCulloch, author of the new study, wrote that in some individuals a medium to high dose of psilocybin could cause profound alterations in consciousness. The R&D being undertaken by entities such as Silo Pharma Inc. (OTCQB: SILO) could also bring to light a lot more about how psilocybin and other psychedelic compounds trigger changes in the brain in order to treat various mental health conditions.

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Thursday's trading session at $0.11, off by 24.1379%, on 151,058 volume. The average volume for the last 3 months is 151,058 and the stock's 52-week low/high is $0.11/$0.2979.

Recent News

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF)

The QualityStocks Daily Newsletter would like to spotlight LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF).

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network, has reported a key corporate update. The company announced that Peter Loretto, an independent director, has resigned from his role. The company indicated that he was resigning for personal reasons. “LQwD would like to thank Mr. Loretto for his contributions, and the Board now consists of Shone Anstey, Ashley Garnot, Pino Perone and Kim Evans,” the company stated in the press release. To view the full press release, visit https://ibn.fm/YpJQb

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) is a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption.

LQwD FinTech’s mission is to develop institutional-grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility, and scaling of bitcoin. LQwD is also securing a substantial position in bitcoin as an operating asset and will use its holdings to establish nodes and payment channels on the Lightning Network.

The Lightning Network is a second-layer protocol, sitting above the bitcoin blockchain, intended to facilitate faster micro-transactions and lower fees on bitcoin transactions, thus allowing mass adoption of bitcoin.

LQwD expects the Lightning Network to eclipse the patchwork of legacy financial networks that are used to move value today. The company’s software will make migration from legacy networks onto the Lightning Network easy and seamless. By onboarding more financial service providers, LQwD intends to grow the value of the Lightning Network.

The company, formerly known as Interlapse Technologies Corp., is harnessing new payment rails built on top of the bitcoin blockchain that are capable of beyond visa-level transaction volumes and backed by bitcoin, the strongest and most well-known cryptocurrency. These new rails, enabled by the Bitcoin Lightning Network, open a vast opportunity and market segment for digital payments and financial services on a global scale. LQwD aims to leverage its position as a public company to enhance trust in its products and services, and leverage its shares as currency for acquisitions, roll-up and growth, as well as to attract and retain top industry talent.

Product

The Lightning Network is a solution to massively scale the use of bitcoin for microtransactions globally, dramatically improving upon fees, as well as providing instant settlement times. The Lightning Network has experienced explosive growth and is expected to continue with the trend as usage increases. Well-known companies, such as Twitter and Square, have expressed their enthusiasm to incorporate Lightning Network into their platforms. The Lightning Network is scalable, global, open, inclusive, permissionless and decentralized. It is made up of nodes connected via payment channels, and enables off-chain, instantaneous and cheap payments at scale.

Upon launch of LQwD’s Lightning Network platform-as-a-service, users will be able to leverage the Lightning Network infrastructure to send payments instantly, securely and inexpensively anywhere in the world. Companies and service providers will be able to conduct Lightning Network transactions in bitcoin by integrating LQwD’s infrastructure with their business or web property. Connected businesses will be able to easily deploy, monitor and manage LQwD’s Lightning Network nodes with no or low-level technical knowledge required. The company fully expects Lightning Network to be a force for global change and to become the monetary exchange network of the future.

The Lightning Network, which is already built, functioning and growing, will advance bitcoin from a store-of-value to a global monetary network through payment utility. The company expects the Lightning Network will propel the growing number of active blockchain wallets to new heights, by increasing bitcoin’s scalability and lowering its fees for users. For coming generations, everything from wealth to experiences will be acquired and transacted virtually, and LQwD sees the Lightning Network as an enabling technology that can bring bitcoin to hundreds of millions of new users across the globe.

Market Outlook

Forbes in August 2021 noted that “private investors are funding companies that are building the infrastructure that will support future growth of crypto and digital assets,” and called public companies building cryptocurrency infrastructure “the hottest part of the crypto market.” While the first wave of investor interest in crypto firms was directed at companies catering to retail investors, investors have now shifted their attention to infrastructure builders, like LQwD FinTech. Forbes did not put an estimated value on the crypto infrastructure market but pointed out that large-scale adoption of cryptocurrencies will only happen when infrastructure is in place to support it. The larger digital payments market, of which crypto payments are a small fraction, is growing at more than 14 percent annually and is forecast to hit $154 billion by 2025.

Management Team

Shone Anstey is co-founder, chairman and CEO at LQwD FinTech. He has 20 years of experience in building complex technologies and has acted as technology lead for an industrial bitcoin mine and bitcoin mining pool. He is a Certified Cryptocurrency Investigator, and an advisor to the British Columbia Securities Commission. He is also co-founder of BIGG Digital Assets (OTCQX: BBKCF) and took that company public in 2017.

Barry MacNeil is CFO at LQwD FinTech. He is a member of the Chartered Professional Accountants of British Columbia and has more than 30 years of management and accounting experience with public companies and in private practice. His previous positions include director of both public companies and nonprofits, as well as Chief Financial Officer and Corporate Controller.

Albert Szmigielski is co-founder and CTO at LQwD FinTech. He was formerly the Head of Research and Chief Blockchain Engineer at Blockchain Intelligence Group and VP Research at CipherTrace. He holds a B.Sc. in Computing Science from Simon Fraser University, and a Master of Science in Digital Currencies and Blockchain Technologies from the University of Nicosia, Cyprus.

LQwD FinTech Corp. (LQWDF), closed Thursday's trading session at $0.1034, off by 13.8333%, on 2,849 volume. The average volume for the last 3 months is 2,849 and the stock's 52-week low/high is $0.0754/$0.694.

Recent News

Cannabis Strategic Ventures Inc. (OTC: NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures Inc. (NUGS).

Earlier this week, the Biden Administration announced that individuals who would like to intern at the White House would be required to disclose any previous drug use. This is despite repeated requests to stop penalizing employees who admit to past use of cannabis. A new White House Internship program FAQ states that applicants going through the hiring process will be required to fill out a security clearance form. The data collected by this form may affect the eligibility of the candidates, especially if it includes information on past consumption of marijuana, even if it was legal under state law. It is this inaction at the highest level of government that is holding back the marijuana industry and entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) from growing their footprint across the country as quickly as they would desire.

Cannabis Strategic Ventures Inc. (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration.

Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually.

Brand Portfolio

The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands.

The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis.

MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability.

Market Outlook

The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market.

According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025.

According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.”

Management Team

Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California.

Cannabis Strategic Ventures Inc. (NUGS), closed Thursday's trading session at $0.0125, off by 7.4074%, on 336,961 volume. The average volume for the last 3 months is 327,261 and the stock's 52-week low/high is $0.012/$0.08.

Recent News

Kronos Advanced Technologies Inc. (OTC: KNOS)

The QualityStocks Daily Newsletter would like to spotlight Kronos Advanced Technologies Inc. (OTC: KNOS).

Kronos Advanced Technologies (OTC: KNOS) has built a reputation for offering some of the most effective, advanced, state-of-the-art air filtration and purification products. “In addition to air filtration systems, the company also offers Kronos(R)-designed graphene N95-compatible face masks made in the United States at a NIOSH-certified facility. Kronos recently announced test results from Nelson Labs demonstrating significant enhanced bacterial filtration efficiency (‘BFE’) and viral filtration efficiency (‘VFE’). According to the update, Kronos’-designed and U.S.-manufactured 5-ply graphene face masks remove 99.9% of bacteria and virus particles compared to the common and far less efficacious ASTM level 4 masks. The company believes that, with BFE and VFE levels over 99.9%, these are the highest filtration efficiency numbers for any face masks in the market,” a recent article reads. “Our goal is to provide the best protective face masks on the market for those in higher-exposure risk environments, with the best technology available,” said Kronos CEO Michael Rubinov. “Our Kronos graphene technology achieves this not only as of the highest protection properties but also by completely reducing the number of viable bacteria and virus particles that are able to pass through the mask materials to zero.” To view the full article, visit https://ibn.fm/bR87W

Kronos Advanced Technologies Inc. (OTC: KNOS) develops and sells a variety of disruptive, advanced, state-of-the-art air filtration and purification systems that fully remove harmful allergens, bacteria, viruses (including the flu), and even gasses from indoor breathing spaces, including healthcare and other settings.

Kronos’ own patented medical-grade technology is tested as the most effective clean air solution on the market. Kronos filters particles down to .0146 micron (.0146μm) – far beyond the 3 microns (0.3μm) of a traditional HEPA filter. Kronos® not only collects but destroys air pollutants. Kronos® AIR 5G® Air Purifiers use about 30,000 volts inside to actively destroy 99.99% of all airborne bacteria, mold, and virus particles.

Kronos® devices operate silently using nanotechnology to remove 100% of pollutants in a 400ft2 room (up to the whole house) and replenishes the room with pure, clean air every 15 minutes. Indoor household air is often four times more polluted than outdoor air, and Kronos air purifiers act like bionic lungs for the home and protect the people in it.

Unlike traditional HEPA systems that collect pollutants on filters which can, over time, grow mold and bacteria, Kronos’ patented technology destroys and eliminates all manner of harmful particles and deposits them on easy-to-clean collecting plates. This reduces the risk of harmful particles in the air and eliminates the need to replace costly HEPA filters every month.

The Kronos® AIR 5G® Air Purifier destroys and eliminates dust, allergens, bacteria, and even viruses. The AIR 5G® has been third party lab tested and confirmed to kill 99.87% of influenza virus in one hour.

The patented system’s five step process starts with a pre-filter screen that filters and collects hair, pet dander, etc. The air is then pulled through emitter wires which create a 30,000-volt electro field that zaps dangerous particulates. In the ionic field, charged particles are destroyed, killing bacteria and pathogens. The particles are then captured on collecting plates, removing dangerous toxins from circulation. The collecting plate is easily cleaned and reused without buying new filters. The catalytic layer is the final step in the purification process, removing odors and keeping the air fresh and pure. The AIR 5G® has Smart Control Auto Mode, which measures and displays the air quality in the room and self-adjusts fan speed based on how dirty the air is in the room. There’s also an AIR 5G® Smart App that displays the real time Air Quality Index and acts as a remote control.

The Kronos® AIR 5G® Air Purifier is offered in three models:

  • Kronos® AIR 5G® X3 air purifier combines powerful patented TPA® technology with a compact form factor up to six times smaller than other air purifiers, with washable and reusable filters.
  • Kronos® AIR 5G® X5 thoroughly wipes out dust, smoke, dander, bacteria, pollen, viruses, odors, germs, and more from the air, delivering the healthiest breathable air possible. It was developed for some of the world’s most polluted areas and is now available for use in the home. It runs completely silently, passing through five stages of purification to guarantee the cleanest possible air in homes or offices.
  • Kronos® AIR 5G® X8 delivers maximum power, more than doubling the capacity and efficiency of the Kronos X5, with CADR speeds of up to 470 CFM – enough to clean a 1,000ft2 room in just 20 minutes.

Kronos also offers the Kronos Car Air Purifier, the most advanced car air purifier with Kronos’ patented TPA® technology, and FitAir, the best personal air purifying solution that brings clean air anywhere by cleaning within 25ft2 of personal space at an airflow rate of 3x per hour.

Market Overview

The global air purifier market was valued at $10.38 billion in 2020 and is expected to reach $21.15 billion by 2027, achieving a CAGR of 10.7% over the forecast period, according to Brandessence Market Research. The market is primarily driven by the increasing concerns about both outdoor and indoor air pollution, coupled with the associated health problems.

Air pollution is one of the most prevalent concerns, due to worsening environmental condition. According to Health Effect Institute, it accounts for 4.9 million to 8.8 million deaths worldwide each year. Furthermore, as most of our time is spent is indoors, indoor air pollution remains a serious concern to individuals, as well as regulatory agencies. Particles like PM 2.5 can enter indoors through a wide range of sources including car engines, fireplaces, and coal- or natural gas and the infiltration of ambient particulates in urban areas. Even in the absence of solid fuels, indoor ventilation can build up PM 2.5 particles to a greater extent than in outdoor environments. Growing demand for portable air purification filters and systems in urban areas, increased advancements to catch key particulates like coronavirus, and increased regulatory measures to ensure safe environments for professionals in the industrial sector remain leading drivers of growth in the air purifier market.

Poor indoor air quality can cause fatigue, headache, and irritation of the eyes, throat, lungs, and nose, which can have a negative impact on worker productivity. Some air contaminants can cause asthma and other respiratory diseases.

Air purifier adoption is increasing rapidly in the U.S. to minimize health issues caused by poor air quality. Strict air quality standards, guidelines, and regulations in the U.S. are expected to have a positive impact on the market. For instance, the New Jersey Indoor Air Quality standard, NJAC 12:100-13 (2007), sets guidelines and standards related to indoor air quality during working hours in public employee-occupied buildings.

Key manufacturers are focusing on acquisitions and mergers to expand their geographical reach and strengthen their position in the market.

Management Team

Michael Rubinov, President and Head of Business Development

A seasoned hi-tech executive with 25 years of global business experience, Mr. Rubinov has served in various positions in sales, marketing, channel development and partner management. He has worked for large and global organizations such as Intel, NICE Systems, and Boeing (Defense and Security), as well as for start-up companies like Dialogic and Remunera International SA. He was appointed President and Head of Business Development of Kronos Advanced Technologies Inc. in February 2020. Mr. Rubinov holds an MBA, an MS Computer Sciences, and a BS Electrical Engineering.

Joseph L. Florence, Chief Operational Officer & CTO

A dynamic skilled leader in all aspects of business formation, evaluation, and execution, Mr. Florence brings a unique combination of Fortune 100 company experience with a lifetime of entrepreneurial experience to the Kronos team. He is a gifted visionary, possessing the unique ability to see future opportunities and make timely strategic adjustments and is naturally gifted at seeing unrecognized risk and overlooked opportunities. Mr. Florence has a proven track record of transforming companies to better align people, processes, and technologies to meet strategic goals and business metrics resulting in increased market share and profitability.

Kronos Advanced Technologies Inc. (OTC: KNOS), closed Thursday's trading session at $0.0125, off by 7.4074%, on 49,766 volume. The average volume for the last 3 months is 49,766 and the stock's 52-week low/high is $0.01/$0.0738.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.